The 2022 OncoAlert Colloquium Day 2: GU Oncology

The 2022 OncoAlert Colloquium Day 1: Breast Cancer

T-DXd demonstrates high levels of efficacy in patients with HER2+ unresectable and/or mBC previously treated with T-DM1

Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML

Comment: POLAR gene profile can identify which patients can safely avoid radiation therapy after breast-conserving surgery

Challenges and opportunities of integrative oncology as an effective tool to enhance cancer prevention and treatment in LMICs.

UICC / WHO Policy dialogue: Maintaining cancer care in times of conflict and environmental emergencies

Addressing women’s cancers: an economic evaluation of breast and cervical cancer interventions in Kenya

Redefining cancer research priorities in the emerging context of the COVID-19 pandemic

Reducing social inequalities in cancer: Evidence and priorities for research

Cancer control in Latin America

Galvanising support for reform: advocacy for cancer control and UHC